1980Drug and Therapeutics BulletinRequires access

Puva for psoriasis and other skin diseases

Author information unavailable

Open publisher page 0 citations

Abstract

Most patients with psoriasis can be treated safely and effectively with dithranol, tar and sensible use of topical corticosteroids.1 Some, however, are not helped by topical therapy and in others the psoriasis relapses very quickly. Systemic cytotoxic drugs or antimetabolites are used for some severe forms of psoriasis, but are potentially hazardous.

About this research paper

What this paper is about

Most patients with psoriasis can be treated safely and effectively with dithranol, tar and sensible use of topical corticosteroids.1 Some, however, are not helped by topical therapy and in others the psoriasis relapses very quickly. Systemic cytotoxic drugs or antimetabolites are used for some severe forms of psoriasis, but are potentially hazardous.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Most patients with psoriasis can be treated safely and effectively with dithranol, tar and sensible use of topical corticosteroids.1 Some, however, are not helped by topical therapy and in others the psoriasis relapses very quickly. Systemic cytotoxic drugs or antimetabolites are used for some severe forms of psoriasis, but are potentially hazardous.

Key concepts: Psoriasis, Dithranol, Dermatology, Medicine, PUVA therapy, tar (computing), Programming language, Computer science

Related papers

Back to paper searchBrowse research topicsOriginal source
Puva for psoriasis and other skin diseases — Research Paper | ScholarLens